163
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Natalizumab: A new treatment for relapsing remitting multiple sclerosis

Pages 259-268 | Published online: 28 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anne Pham-Huy, Manish Sadarangani, Vivian Huang, Monika Ostensen, Eliana Castillo, Sarah M. Troster, Wendy Vaudry, Geoffrey C. Nguyen & Karina A. Top. (2019) From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert Review of Clinical Immunology 15:3, pages 221-229.
Read now
Agnese Gugliandolo, Federica Longo, Maria Giovanna Marrosu, Giovanni Luigi Mancardi, Ilaria Gandoglia, Maurizio Melis, Fabrizio Lo Giudice, Placido Bramanti & Emanuela Mazzon. (2018) A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients. Therapeutics and Clinical Risk Management 14, pages 1765-1788.
Read now
Emanuele D’Amico, Aurora Zanghì & Francesco Patti. (2017) Can new chemical therapies improve the management of multiple sclerosis in children?. Expert Opinion on Pharmacotherapy 18:1, pages 45-55.
Read now